We aspire to help patients and clinicians confront the most challenging cancers in modern medicine

Kazia’s drug candidates are designed to treat diseases such as brain cancer, renal cancer, and liver cancer, which are poorly served by existing therapies

Click here to access resources for patients

If you are a Kazia shareholder and want information on how to convert your unlisted shares to ADSs, please click on the link below.

Click here

We draw on the best research available, and partner with the world’s leading experts in cancer treatment

Kazia’s unique strength lies in the ability to identify promising undervalued drug candidates around the world, and to collaborate with researchers to discover and develop their potential

Click here to access resources for partners